Prentice Wealth Management LLC 9 Meters Biopharma, Inc. Transaction History

Prentice Wealth Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	BUY	$0.21 - $0.32 $9,665 - $14,728	46,025 New	46,025 $10,000
Q2 2022 Jul 28, 2022	SELL	$0.26 - $0.64 $7,540 - $18,560	-29,000 Closed	0 $0
Q1 2022 Oct 31, 2022	SELL	$0.52 - $1.0 $3,380 - $6,500	-6,500 Reduced 14.12%	39,525 $23,000
Q4 2021 Oct 31, 2022	SELL	$0.85 - $1.33 $9,371 - $14,663	-11,025 Reduced 23.95%	35,000 $34,000
Q3 2021 Nov 10, 2021	BUY	$1.03 - $1.41 $11,124 - $15,228	10,800 Added 59.34%	29,000 $38,000
Q2 2021 Aug 11, 2021	BUY	$1.04 - $1.5 $6,032 - $8,700	5,800 Added 46.77%	18,200 $20,000
Q1 2021 Jun 17, 2021	SELL	$0.84 - $2.16 $1,770 - $4,553	-2,108 Reduced 14.53%	12,400 $15,000
Q1 2021 Jun 08, 2021	BUY	$0.84 - $2.16 $12,186 - $31,337	14,508 New	14,508 $15,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Prentice Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Prentice Wealth Management LLC with notifications on news.